Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions

B Wang, L Zhang, Y Wang, T Dai, Z Qin… - Signal transduction and …, 2022 - nature.com
The global coronavirus disease 2019 (COVID-19) pandemic is currently ongoing. It is
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A high …

Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review

Y Farsi, A Tahvildari, M Arbabi, F Vazife… - Frontiers in cellular …, 2022 - frontiersin.org
Introduction The Coronavirus Disease 2019 (COVID-19) pandemic caused by Severe Acute
Respiratory Coronavirus 2 (SARS-CoV-2) emerged in late December 2019. Considering the …

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

F Zhang, RI Lau, Q Liu, Q Su, FKL Chan… - Nature Reviews …, 2023 - nature.com
The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …

Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection

K Krasaewes, R Chaiwarith, N Chattipakorn… - Life Sciences, 2023 - Elsevier
The correlation between SARS-CoV-2 infection and gut microbiota has been a subject of
growing interest in recent research endeavors. It is postulated that SARS-CoV-2 might lead …

Microbiota and COVID-19: Long-term and complex influencing factors

J Gang, H Wang, X Xue, S Zhang - Frontiers in Microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the World Health …

SARS-CoV-2-indigenous microbiota nexus: does gut microbiota contribute to inflammation and disease severity in COVID-19?

I Chattopadhyay, EM Shankar - Frontiers in cellular and infection …, 2021 - frontiersin.org
Gut microbiome alterations may play a paramount role in determining the clinical outcome of
clinical COVID-19 with underlying comorbid conditions like T2D, cardiovascular disorders …

Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections

Y He, J Wang, F Li, Y Shi - Frontiers in Microbiology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
(SARS) coronavirus 2 (SARS-CoV-2), has become a pandemic, infecting more than …

The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment

M Wang, Y Zhang, C Li, W Chang, L Zhang - Frontiers in Immunology, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has posed a global health crisis. Increasing …

Gut microbiota status in COVID-19: an unrecognized player?

S Donati Zeppa, D Agostini, G Piccoli… - Frontiers in cellular …, 2020 - frontiersin.org
Infection with the SARS-CoV-2 virus causes cardiopulmonary and vascular complications,
ranging in severity. Understanding the pathogenic mechanisms of the novel SARS-CoV2 …

Gut microbiota diversity and C-reactive protein are predictors of disease severity in COVID-19 patients

A Moreira-Rosário, C Marques, H Pinheiro… - Frontiers in …, 2021 - frontiersin.org
The risk factors for coronavirus disease 2019 (COVID-19) severity are still poorly
understood. Considering the pivotal role of the gut microbiota on host immune and …